Sign In

Ranjan Sinha

Founder & CEO @ DIGBI HEALTH | Precision Biology - Genetics, Gut microbiome- Based Care for chronic lifestyle illnesses

Ranjan Sinha is a seasoned professional with over 33 years of experience in the business and health sectors. With a strong interest in advancing care for inflammatory digestive and obesity-related illnesses, he leads Digbi Health, a pioneering company utilizing genetics, gut microbiome, and AI to provide personalized, proactive, and data-driven home-based solutions. Ranjan actively engages with industry organizations like the American College of Lifestyle Medicine and the American College of Gastroenterology to promote lifestyle medicine missions and collaborate with peers.

Highlights

Aug 26 · linkedin

Six in 10 adult Americans may eventually rely on GLP drugs for weight and metabolic health management. Understanding the crucial role of GLP hormones and drugs is key to healthy living. While GLPs are effective, real-world evidence highlights significant variations in outcomes based on individual biology, with some experiencing weight gain.

At Digbi Health, leaders in Precision biology-based #Obesity and #digestivehealth care, we emphasize tailoring interventions at genetic and microbiome levels to enhance outcomes for individuals on GLP drugs and deliver ROI for employers.

Our personalized, microbiome-targeted approach utilizes #foodasmedicine to modulate the #gutmicrobiome, supporting natural regulatory mechanisms to complement GLP pharma intervention. This strategy enhances metabolic health, offering a sustainable path for weight management and potentially reducing medication dependency over time.

WTW Mercer Health Transformation Alliance #GLP #MetabolicHealth #PrecisionMedicine #WeightManagement #DigbiHealth #HealthyLiving

Aug 11 · linkedin

A timely article by Blake Madden.
Based on our experience managing GLP programs for employers at Digbi Health, I've seen the power of GLP-1 drugs to improve health and the fantastic contribution of Novo Nordisk and Eli Lilly and Company in bringing these to market.
I even see firsthand the critical role quality compounding pharmacies play. These pharmacies are regulated under strong oversight and have a proven track record of handling complex drugs—often as intricate as GLPs. Their services range from hormone replacement therapy and pain management to pediatric and dermatologological preparations, allergy meds, bioidentical hormones, and thyroid meds. Every compounded drug is prescribed and closely monitored by a licensed MD, ensuring safety.

Compounding is often the only way to personalize drug dosage and titration, which is vital for those who struggle with side effects—something we see in over 40% of GLP users. With the current shortage of branded GLP drugs, many patients are left searching for alternatives, often with no success. Compounding pharmacies have stepped in, providing the necessary medications and safeguarding patient health during these challenging times.

When patients lose coverage or change jobs, compounded drugs often become the only option they can afford to safeguard their health. It's crucial to recognize and support the vital work these pharmacies do in protecting patient health and access. WTW Aon Brown & Brown Insurance Mercer Dr. Garima Sharma

Ranjan Sinha
Add to my network

Location

Los Altos, California, United States